ES2157498T3 - Derivados de triazol o sus sales. - Google Patents

Derivados de triazol o sus sales.

Info

Publication number
ES2157498T3
ES2157498T3 ES97109942T ES97109942T ES2157498T3 ES 2157498 T3 ES2157498 T3 ES 2157498T3 ES 97109942 T ES97109942 T ES 97109942T ES 97109942 T ES97109942 T ES 97109942T ES 2157498 T3 ES2157498 T3 ES 2157498T3
Authority
ES
Spain
Prior art keywords
triazol
group
derivatives
salts
derivative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97109942T
Other languages
English (en)
Inventor
Minoru Tokizawa
Sunao Takeda
Yasushi Kaneko
Hiromichi Eto
Kazuya Ishida
Kazunori Maebashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SSP Co Ltd
Original Assignee
SSP Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SSP Co Ltd filed Critical SSP Co Ltd
Application granted granted Critical
Publication of ES2157498T3 publication Critical patent/ES2157498T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
    • C07D303/02—Compounds containing oxirane rings
    • C07D303/34—Compounds containing oxirane rings with hydrocarbon radicals, substituted by sulphur, selenium or tellurium atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

SE DESCRIBE UN DERIVADO DEL TRIAZOL REPRESENTADO POR LA FORMULA (1): DONDE R REPRESENTA UN ATOMO DE HIDROGENO, UN GRUPO ALQUILO, UN GRUPO ARALQUILO O UN GRUPO ACILO, N REPRESENTA UN VALOR DE 0 A 2 Y M REPRESENTA UN VALOR DE 1 A 5, O UNA SAL DERIVADA, Y UN COMPUESTO FARMACEUTICO QUE CONTENGA EL DERIVADO O LA SAL COMO INGREDIENTE EFECTIVO.
ES97109942T 1996-06-21 1997-06-18 Derivados de triazol o sus sales. Expired - Lifetime ES2157498T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16176096 1996-06-21

Publications (1)

Publication Number Publication Date
ES2157498T3 true ES2157498T3 (es) 2001-08-16

Family

ID=15741381

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97109942T Expired - Lifetime ES2157498T3 (es) 1996-06-21 1997-06-18 Derivados de triazol o sus sales.

Country Status (7)

Country Link
US (2) US5939448A (es)
EP (1) EP0814079B1 (es)
KR (1) KR100257549B1 (es)
CN (1) CN1172108A (es)
CA (1) CA2207484A1 (es)
DE (1) DE69704396T2 (es)
ES (1) ES2157498T3 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438784B (en) * 1997-08-29 2001-06-07 Ssp Co Ltd Triazole derivative or salt thereof and pharmaceutical composition for treating mycosis containing the same
JP3638438B2 (ja) 1997-12-26 2005-04-13 エスエス製薬株式会社 トリアゾール誘導体またはその塩、その製造方法及び当該化合物を有効成分とする医薬
EP0933368A1 (en) * 1998-02-02 1999-08-04 SSP Co., Ltd. Triazole derivative or salt thereof, preparation process thereof and pharmaceutical containing said compound as an effective ingredient (antimycotic)
JP2000226368A (ja) 1999-02-04 2000-08-15 Ss Pharmaceut Co Ltd ジフルオロアセトフェノン誘導体の製造法
KR20010050557A (ko) 1999-09-29 2001-06-15 타이도 나오카타 아졸 유도체 또는 그의 염
EP2894981B1 (en) * 2012-09-12 2019-12-04 Dow AgroSciences LLC Metalloenzyme inhibitor compounds

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG48681A3 (bg) * 1982-12-14 1991-04-15 Ciba - Geigy Ag Фунгицидно средство
KR930004193B1 (ko) * 1984-10-02 1993-05-21 스미또모 세이야꾸 가부시끼가이샤 N-치환된 트리아졸 유도체의 제조방법
US4999429A (en) * 1989-01-09 1991-03-12 Ethyl Corporation Process for the preparation of α,α,β-1-trifluoro-1-olefinic derivatives
JPH0383973A (ja) * 1989-08-28 1991-04-09 Sumitomo Pharmaceut Co Ltd エポキシ体のスレオ選択的製造法
CA2031892C (en) * 1989-12-25 2000-08-01 Minoru Tokizawa Triazole derivatives
JP3471831B2 (ja) * 1991-12-09 2003-12-02 富山化学工業株式会社 新規なトリアゾール誘導体およびその塩

Also Published As

Publication number Publication date
DE69704396T2 (de) 2001-07-05
EP0814079A1 (en) 1997-12-29
US5939448A (en) 1999-08-17
KR980002033A (ko) 1998-03-30
CN1172108A (zh) 1998-02-04
DE69704396D1 (de) 2001-05-03
KR100257549B1 (ko) 2000-07-01
US6063945A (en) 2000-05-16
CA2207484A1 (en) 1997-12-21
EP0814079B1 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
ES2142000T3 (es) Derivados del acido metoxiiminoacetico y fungicidas agricolas y horticolas que los contienen como ingrediente activo.
MX9303158A (es) Derivados de aminoquinolona substituidos con grupoarilo o con un grupo heterociclico aromatico; y agente anti-vih.
LU91210I2 (fr) Emodepside & Praziquantel ainsi que leurs dérivés pharmaceutiqement acceptables (PROFENDER)
ES2182852T3 (es) Derivados de prolinamida.
DE69221290D1 (de) Auf aromatischen sulfonamiden basierende hydroxamsäurederivate
ES2058069T3 (es) Derivados de 5h-1,3,4-tiadiazolo-(3,2-a)-pirimidin-5-ona y nuevo compuesto fungicida agricola-horticola que contiene dicho derivado.
ES2179071T3 (es) Agentes vasodilatadores perifericos que comprenden como principio activo derivados de la piperidina 4-amino n-acilada.
BR0108303A (pt) Derivados do 1h-imidazopiridina
ES2171416T3 (es) Remedio contra la trombocitopenia.
DK0471236T3 (da) Imidazopyridinderivater og deres anvendelse
MX9100607A (es) Compuesto triciclico novedoso o sales del mismo,metodo para producir el mismo y agente antimicrobiano que lo contiene
ES2069281T3 (es) Derivado de fenantreno.
DK0593766T3 (da) Pyridoncarboxylsyrederivat
MD1560F2 (en) Cyclic compounds, pharmaceutical compositions on base thereof and methods of treatment of infections or diseases provoked by retroviruses.
EA200100916A1 (ru) Лекарственное средство, содержащее производное сульфопиранозилацилглицерина
ATE66675T1 (de) Stickstoffhaltige heterozyklische verbindungen.
ES2190471T3 (es) Procedimiento para producir derivados de guanidina, intermedios de dichos compuestos y su produccion.
ES2157498T3 (es) Derivados de triazol o sus sales.
ES2091489T3 (es) Derivados de imidazol y composiciones farmaceuticas que los contienen.
ES2055026T3 (es) Derivados de cicloalcanoles sustituidos con azol, un procedimiento para producirlos y un uso de los derivados como un fungicida agricola y horticola.
ES2189736T3 (es) Derivados de la benzamida y medicamentos que los contienen.
TW344743B (en) Therapeutic nucleosides
SE8903312L (sv) New 2-carbonyl substituted n,n'-di-(trimethoxybenzol)piperazines, process for preparing the same and therapeutical compounds containing them
HU9904686D0 (en) New hydroxy-bicyclolactam derivatives, their use and medicaments containing them
MX9203068A (es) Compuestos activirales oralmente activos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 814079

Country of ref document: ES